News

BioMarin has announced that the FDA has granted orphan drug designation for 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate, for autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has previously received

Allos has reported that the US Patent and Trademark Office (USPTO) has issued a patent for the use of Folotyn (pralatrexate injection) for the treatment of T-cell lymphoma.

Suven Life Sciences has secured three patents EP1537113, EP1704154 and EP1856132 issued by European Patent Office (EPO).These patents corresponds to three New Chemical Entities (NCEs) for the treatment

Sanofi-aventis Canada has entered into a licensing agreement with Intelliject for a novel epinephrine auto injector for the emergency treatment of allergic reactions (anaphylaxis) in North America (US

The European Commission has granted marketing authorisation for Sanofi’s Multaq (dronedarone – 400mg tablets) in all 27 European member states. This approval follows the European Commission positive opinion

The Defense Threat Agency (DTRA), on behalf of the US Air Force Assistant Surgeon General, Modernisation Directorate (AF/SGR), has awarded Idaho Technology, a $3.3m to advance development of

PositiveID has entered into a strategic alliance with Innovations Avocare (Avocare), to develop, implement, distribute and use PositiveID’s Health Link personal health record (Health Link) within the medical

Vida Diagnostics (Vida) and Veran Medical Technologies (Veran Medical ) have signed a definitive agreement covering joint development and distribution of an endobronchial lung navigation and biopsy system.

David Simmons president and general manager said that Pfizer is banking on its alliance with Aurobindo Pharma to turn around its generic medicines unit and drive overall growth,